# A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation

> **NCT00216190** · PHASE4 · COMPLETED · sponsor: **Hospira, now a wholly owned subsidiary of Pfizer** · enrollment: 420 (actual)

## Conditions studied

- Mechanically Ventilated and Intubated Subjects

## Interventions

- **DRUG:** Dexmedetomidine HCL Injection
- **DRUG:** Midazolam Injection

## Key facts

- **NCT ID:** NCT00216190
- **Lead sponsor:** Hospira, now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2015-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216190, "A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00216190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*